SHIELDS, MD, L. B. E.; JOHNSON, BS, T. A.; DANIELS, MS, M. W.; BELL, MSN, RN, CPN, A.; SIEMENS, PHARMD, D. M.; JENNINGS, MD, MBA, J. T.; HESTER, MD, MBA, S. T.; HONAKER, MD, MBA, FAAP, J. T. Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force. Journal of Opioid Management, [S. l.], v. 17, n. 2, p. 155–167, 2021. DOI: 10.5055/jom.2021.0625. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/2925. Acesso em: 6 may. 2024.